The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
The Insides Company Receives B-Corp Certification

The Insides Company Receives B-Corp Certification

July 10, 2023

Source:The Insides Company Limited

On:10th July 2023

Companies:The Insides Company Limited, B Lab

The Insides Company, a developer and manufacturer of the world’s first range of chyme reinfusion devices, has become the latest company to achieve certification as a B-Corp.

Certified B Corporations are leaders in the global movement for an inclusive, equitable, and regenerative economy. The B-Corp process is a rigorous and independent assessment of a company's impact on people and the planet, from carbon footprint to employee empowerment.

Joining a global community of over 6,000 purpose-led businesses that meet the high standards of sustainability and social responsibility required for B Corp certification is a testament to The Insides Company’s commitment to incorporating social responsibility in the business model.

The Insides Company’s dual focus on supporting both patients and the environment aligns with countries such as Norway and Denmark which are leading the way with requirements for recycling and sustainability in their regulatory review process.

“Becoming only the 9th medical / dental manufacturer in the world to receive a B-Corp certification helps The Insides Company to align its business with its values, and it also helps to raise awareness of the issue of intestinal failure”, said Rob Davidson, CTO of The Insides Company.

Choose Your Language

Selecting language below will change the language for